I. Smith

发表

Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT.

Isabelle L Smith, C. McCabe, C. Hulme, 2019, Health technology assessment.

Pressure UlceR Programme Of reSEarch (PURPOSE): using mixed methods (systematic reviews, prospective cohort, case study, consensus and psychometrics) to identify patient and organisational risk, develop a risk assessment tool and patient-reported outcome Quality of Life and Health Utility measures

Isabelle L Smith, M. Patterson, C. Czoski-Murray, 2015 .

Pressure Relieving Support Surfaces for Pressure Ulcer Prevention (PRESSURE 2): Clinical and Health Economic Results of a Randomised Controlled Trial

Isabelle L Smith, C. Hulme, J. Nixon, 2019, EClinicalMedicine.

Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial

Isabelle L Smith, D. Stocken, R. Mújica-Mota, 2022, BMJ Open.

Consensus study reduced format protocol

Jane Nixon, Malcolm Patterson, Nikki Stubbs, 2015 .

Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2) photographic validation sub-study: study protocol for a randomised controlled trial

Isabelle L Smith, J. Nixon, A. Nelson, 2017, Trials.

Clinical evaluation of a new pressure ulcer risk assessment instrument, the Pressure Ulcer Risk Primary or Secondary Evaluation Tool (PURPOSE T)

Isabelle L Smith, C. Dealey, J. Nixon, 2017, Journal of advanced nursing.

Treatment of severe, chronic hand eczema: results from a UK‐wide survey

S. Tubeuf, M. Wittmann, J. Nixon, 2017, Clinical and experimental dermatology.

The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials

Benjamin Thorpe, Isabelle L Smith, Julian P. T. Higgins, 2017, Trials.

A patient-reported pressure ulcer health-related quality of life instrument for use in prevention trials (PU-QOL-P): psychometric evaluation

Isabelle L Smith, J. Nixon, Julia M. Brown, 2018, Health and Quality of Life Outcomes.

Extended Intensified Post-ASCT Consolidation with Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (Dara-VRd) for Ultra-High Risk (UHiR) Newly Diagnosed Myeloma (NDMM) and Primary Plasma Cell Leukemia (pPCL): The UK Optimum/Muknine Trial

R. Houlston, M. Drayson, M. Jenner, 2022, Blood.

Pressure ulcer and wounds reporting in NHS hospitals in England part 1: Audit of monitoring systems.

Jane Nixon, Lyn Wilson, Susanne Coleman, 2016, Journal of tissue viability.

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial

Isabelle L Smith, R. Huddart, J. Snowden, 2019, PLoS medicine.

Comparison of generic and disease‐specific measures in their ability to detect differences in pressure ulcer clinical groups

Isabelle L Smith, D. Costa, J. Nixon, 2019, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Exploring the role of pain as an early predictor of category 2 pressure ulcers: a prospective cohort study

Isabelle L Smith, C. Dealey, J. Nixon, 2017, BMJ Open.

Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial

Isabelle L Smith, C. Hulme, J. Nixon, 2016, Trials.

Pressure relieving support surfaces: a randomised evaluation 2 (PRESSURE 2)

Isabelle L Smith, C. Hulme, J. Nixon, 2013, Trials.

Pressure ulcer and wounds reporting in NHS hospitals in England part 2: Survey of monitoring systems.

J. Nixon, S. Coleman, Sarah R Brown, 2016, Journal of tissue viability.

Power and sample size for multistate model analysis of longitudinal discrete outcomes in disease prevention trials

Isabelle L Smith, Linda Sharples, Jane E Nixon, 2021, Statistics in medicine.

Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial

Isabelle L Smith, J. Lear, S. Tubeuf, 2022, BMJ Open.